|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/505 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/505 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3515446 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17778357.8 |
| Date of filing the European patent application | 2017-09-18 | |
| (97) | Date of publication of the European application | 2019-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2017/055641 |
| Date | 2017-09-18 |
| (87) | Number | WO 2018/051306 |
| Date | 2018-03-22 |
| (30) | Number | Date | Country code |
| 201662396504 P | 2016-09-19 | US |
| (72) |
CAPONIGRO, Giordano , US
MEYER, Matthew John , US
COOKE, Vesselina , US
STUART, Darrin , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | THERAPEUTIC COMBINATIONS COMPRISING A RAF INHIBITOR AND A ERK INHIBITOR |
| THERAPEUTIC COMBINATIONS COMPRISING A RAF INHIBITOR AND A ERK INHIBITOR |